We use cookies to improve your experience on our Website. We need cookies to continuously improve the services, to enable certain features and when embedding services or content of third parties, such as video player. By using our website, you agree to the use of cookies. We use different types of cookies. You can personalize your cookie settings here:

Show detail settings
Please find more information in our privacy statement.

There you may also change your settings later.

German Diabetes Study (GDS)

This study is investigating how an existing diabetes mellitus develops in the long term after diagnosis.

Background of the Study

The German Diabetes Study observes patients with newly diagnosed type 1 or type 2 diabetes for a period of 10 years. Thus, early warning signs for later complications can be discovered, and all approved therapy procedures can be compared in parallel. The study also investigates the influence of heredity (genes) on disease progression.

The study is being conducted at seven locations within the framework of the German Center for Diabetes Research (DZD) in Germany.

 

 

Suitable Participants    

  • Men and women between 18 and 69 years of age
  • With type 1 or type 2 diabetes; diagnosis made not more than 1 year prior to enrollment in the study or healthy control participants without diabetes
  • All treatment forms allowed (dietary, pills, injections, insulin therapy)

 

Most Important Exclusion Criteria

  • Age under 18 or over 69 years
  • Certain endocrine diseases/disorders of the hormone system
  • Chronic gastrointestinal diseases
  • Mental illness, addiction
  • Anti-inflammatory or immunosuppressive therapy
  • Acute or chronic infectious diseases
  • Malignant tumor diseases (cancer)
  • Certain liver and gallbladder diseases
  • Kidney failure
  • Anemia
  • Particular coagulation disorders
  • Pregnancy

 

Course of the Study

At the start of the study, and after 5 and 10 years, several days of examinations take place. These include different metabolic tests, if necessary the taking of blood samples and adipose tissue samples, several examinations of the nervous system and the cardiovascular system, and a magnetic resonance tomography of the liver (MRI).

In between you will be contacted once a year to track the progress of your disease.

There is NO additional medication within the framework of the clinical study. The study ends after a total of 10 years.

 

Examinations

  • Physical examination by a doctor
  • Body measurements (weight, height, hip and waist circumference)
  • Blood samples
  • Metabolic tests (measurement of remaining endogenous insulin secretion and insulin sensitivity using various laboratory methods)
  • Examination of the nervous system (variability of the pulse rate, neuropathy tests)
  • Examination of the cardiovascular system (measurement of blood pressure, blood vessel tests, ECG)
  • MRI (magnetic resonance imaging of intra-abdominal fat and liver fat content)

 

Compensation for Expenses

All examinations are free of charge for you. The costs are borne by the Center. Please inquire about a financial compensation at the respective study center.

Participating Clinics:

Düsseldorf
PD Dr. Julia Szendrödi
German Diabetes Center
Phone: 0211–3382209


Tübingen
Prof. Andreas Fritsche, Prof. Norbert Stefan,
Tübingen University Hospital
Phone: 07071–2980687


Berlin/Potsdam
Prof. Andreas Pfeiffer
German Institute of Human Nutrition /
Charité Berlin
Phone: 033200–882778 oder 882774


Munich
Prof. Jochen Seißler, Dr. Andreas Lechner
Ludwig-Maximilians-Universität
Phone: 089–4400–52234


Heidelberg
Prof. Peter Nawroth
Heidelberg University Hospital
Phone: 06221 56-8606
 


Dresden
Dr. Sabine Fischer
Dresden University Hospital
Phone: 0351 4583701


Leipzig
Prof. Michael Stumvoll, Dr. Gesine Flehmig
Leipzig University Hospital
Phone: 0341-9720728

http://ifb-adipositas.de/plis


Lübeck
Prof. Sebastian Schmid
Schleswig-Holstein University Hospital
Phone: 0451 3101 7864
dds(at)uksh.de